Clinical Trials - July 25, 2015
Drug Tested for Rare Epilepsy
Lundbeck LLC has initiated the CLOVER I Study to investigate the use of clobazam for the treatment of children and adolescents with Dravet syndrome — a rare and severe form of epilepsy that begins in infancy. The drug already is approved in the U.S. for seizures associated with another epilepsy syndrome. The study is designed […]
